Co-Occurring Substance Use Disorder & Mental Illness
Recognizing the co-occurrence of substance use disorder alongside mental health disorders is necessary to identify appropriate treatments and medications to improve a patient’s health and well-being.
In this session, we will provide providers with a greater understanding and awareness of the growing population of co-occurring substance use and mental health disorders and the attached stigma in the post-acute and long-term care settings. We will cover background information of both disorders as well as the treatment guideline information needed to provide up-to-date care. Additionally, we will address specific medication administration guidelines and medications to avoid in this population.
Tuesday, November 12, 2024
1:00 pm ET
Presented by:
Angela Edmonds, RPh, PharmD, Consultant Pharmacist, PharMerica
Learning Objectives:
1. Ability to define co-occurring substance use disorder and mental illness.
2. Ability to identify appropriate treatments and medications used for co-occurring substance use disorder and mental illness.
3. Be able to describe specific medication guidelines.
CE STATEMENT
This program has been approved for 1 participant hour of nursing continuing education, as well as by NAB/NCERS for nursing home administrators (approval #20250807-1-A104633-DL) and by NABP for pharmacists (approval #0854-9999-24-031-L04-P). Attendees must be in attendance for at least 50 minutes to receive credit.